ReviewMolecules (Basel, Switzerland)2026
Flavonoids as Potential Therapeutic Agents Against Gastrointestinal Pathogen Growth and Their Mechanisms of Action: A Comprehensive Review.
Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The increasing prevalence of gastrointestinal infections, along with growing resistance to conventional antibiotics, has driven the search for alternative antibacterial agents including flavonoids, which are widely recognised for their antimicrobial properties. Flavonoids exhibit broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria through multifactorial mechanisms, disrupting multiple bacterial cellular processes, including energy metabolism, membrane integrity, and protein synthesis. Several studies have highlighted the antimicrobial potential of flavonoids against gastrointestinal pathogens, with some evidence suggesting minimal disruption to beneficial intestinal microflora. Most investigations have primarily focused on in vitro assessments of antibacterial activity, with limited in vivo studies and insufficient therapeutic or clinical evaluation. Consequently, their efficacy in physiological systems and the underlying mechanisms of action remain inadequately understood. Studies should also examine the antimicrobial activity of flavonoids against a wider panel of gastrointestinal pathogens. Also, the panel of flavonoids previously evaluated for their antibacterial activity is relatively narrow and many compounds have been neglected to date. Multiple other flavonoids remain to be evaluated for antimicrobial activity against gastrointestinal pathogens. This review focuses on the antimicrobial activity of different classes of flavonoids against gastrointestinal pathogens. Additionally, we discuss the interaction of selected flavonoids with conventional antibiotics. Furthermore, their mechanisms of action (where known) are also discussed to focus attention on the use of this important class of molecules as antibiotic therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.